NovoCure Ltd — Director's Dealing 2018

Feb 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-02-22

Reporting Person: Kirson Eilon D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-22	Ordinary Shares	M	36401	$21.55	Acquired	39582	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-22	Restricted Stock Units	$0.00	M	36401	Acquired		Ordinary Shares (36401)	Direct

Footnotes

F1: Fully vested as of the date hereof.